lorazepam has been researched along with Diabetic Ketoacidosis in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Diabetic Ketoacidosis: A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cawley, MJ | 1 |
1 other study available for lorazepam and Diabetic Ketoacidosis
| Article | Year |
|---|---|
Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review.
Topics: Adult; Cocaine-Related Disorders; Critical Care; Diabetic Ketoacidosis; Excipients; Female; Hemodyna | 2001 |